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Abstract
Background: The purpose of this study was to evaluate the virulence profiles of Pseudomonas aeruginosa clinical
strains recently isolated from patients hospitalized for chronic leg ulcers in the Dermatology Department of Central
Military Emergency University Hospital “Carol Davila”, Bucharest, Romania.
Methods: The phenotypic screening evaluated eight soluble virulence factors (haemolysins, lecithinase, lipase,
caseinase, gelatinase, amylase, DNase, aesculin hydrolysis), as well as adherence ability (Cravioto adapted method)
and invasion capacity on HeLa cells (gentamicin protection assay). Seven virulence genes encoding for protease IV,
3 exoenzymes (exoS, exoT, exoU), two phospholipases plcH- haemolytic phospholipase C and plcN- non-haemolytic
phospholipase C) and alginate were investigated by PCR.
Results: The pore forming toxins and enzymes were expressed in variable proportions, the majority of the tested
strains producing beta haemolysin (92.3 %), lipase (76.9 %) and lecithinase (61.5 %). The most frequent virulence
genes detected in the analyzed strains were the ExoT (100 %) and AlgD (92.3 %) genes, genes codifying for
phospholipases (84.6 % each of them) and for protease IV (61.5 %).
Conclusions: This study reveals that correlating virulence profiles and infection clinical outcome is very useful for
setting up efficient preventive and therapeutic procedures for hospitalized patients with chronic leg ulcers and
positive P. aeruginosa cultures.
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Background
Chronic leg ulcers represent a clinically highly relevant topic,
this condition affecting 1–2 % of the general population and
being responsible for increased morbidity and impaired
quality of life. Pseudomonas aeruginosa, one of the most
common bacteria isolated from chronic wounds [1], is an
opportunistic pathogen with innate resistance to many
antibiotic classes, including antipseudomonal penicillins,
carbapenems, aminoglycosides and ciprofloxacin [2, 3].
Treatment options for infections caused by antibiotic resistant
P. aeruginosa is limited to carbapenems, but increasing resist-
ance rates mediated in most cases by the production of carba-
penemases such as metallo-β-lactamases (MBLs) are reported
[4, 5]. In case of P. aeruginosa isolated from chronic wounds
there is no consensus on the first-line antibiotic to be used [6].
Besides intrinsic and acquired resistance to many antibi-
otics, P. aeruginosa expresses many extracellular virulence
factors (exotoxins S and T with ADP-ribosylating activity
which cause disruption of the host cell cytoskeleton,
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cytotoxin ExoU with phospholipase activity and cytotoxin
Exo Y with an adenylate cyclase activity, phospholipases,
protease IV and elastase) and surface associated compo-
nents, as alginate. All these factors contribute to massive
tissue damage, blood infection dissemination, and progres-
sion of the disease, and also limit treatment options with
currently available antibiotics [7, 8]. A retrospective multi-
center evaluation of 970 patients with chronic leg ulcer
treated in different dermatologic wound care centers from
Germany revealed that P. aeruginosa was found in 31.1 % of
the analyzed cases and a positive correlation regarding
wound size and duration was observed [9]. Because in many
cases chronic leg ulcers are associated with diabetes, and
taking into account the high resistance of this species, per-
sistence of P. aeruginosa in these patients was observed. In a
longitudinal survey regarding patients with non-healing ven-
ous ulcers, P. aeruginosa was isolated ≥ 3 years from the
same patients, and a longer wound duration compared to all
analyzed patients was revealed [10].
Considering the above mentioned aspects and taking
into account the lack of such studies on Romanian
strains the purpose of this study was to investigate the
phenotypic and genotypic profile of P. aeruginosa strains
isolated from Romanian patients with chronic leg ulcers.
Methods
Isolation and identification of bacterial strains
This study was conducted on a total of 12 P. aeruginosa
clinical strains isolated during July 2013 - June 2015, from
130 patients hospitalized for chronic leg in the Depart-
ment of Dermatology of the Central Military Emergency
University Hospital “Carol Davila”, Bucharest, Romania.
The patient or the legally authorized representative had to
be able to read and sign the informed consent. Swab
samples were collected for aerobic bacterial culture. The
swabs were transported in thioglycolate broth media and
then transferred on 5 % sheep blood agar. Cultures were
incubated at 37 °C aerobically for 24 h. The identification
of microbial isolates was performed using Gram staining,
conventional biochemical tests and API BioMerieux
systems (20NE).
Evaluation of the soluble enzymatic factors
The virulence phenotypes were assessed by performing
enzymatic tests for the expression of some soluble virulence
factors. Overnight culture of the strains was evaluated for
the following virulence factors expression: haemolysins,
other pore forming toxins (lecithinase, lipase), proteases
(caseinase, gelatinase), amylase and aesculin hydrolysis.
Detection of haemolysin production was performed by
spotting the fresh cultures on 5 % sheep blood agar
medium and incubation at 37 °C for 24 h. The colorless
area around the culture revealed the presence of haemolysis
activity. For lipase production the strains were spotted on
1 % Tween 80 agar as a substrate and followed by incuba-
tion at 37 °C for 24 h. An opaque (precipitation) zone
around the spot was registered as positive reaction; for leci-
thinase production, the cultures were spotted into 2.5 %
yolk agar and incubated at 37 °C for 24 h. A clear zone
around the spot indicated the lecithinase production. The
protease activity (caseinase and gelatinase) was determined
using 15 % soluble casein agar, respectively 3 % gelatin as
substrate. The strains were spotted and after incubation at
37 °C for 24 h, a white precipitate surrounding the growth
indicated casein proteolysis, and colorless area around
culture due to the gelatin hydrolysis, indicated the positive
reaction for gelatinase. Amylase was detected using agar
with 1 % starch and hydrolysis was revealed after adding
Lugol's solution (yellow ring around the culture, while the
rest of the plate will be blue). For the aesculin hydrolysis
the medium containing Fe 3+ citrate was used and inocu-
lated by spotting, then incubated for 24 h at 37 °C. A black





Amylase Caseinase Lecithinase Lipase Gelatinase Haemolysin PLCH PLCN ExoU ExoT AlgD ExoS TCF/
TCR
1 1333(1) - + + +++ + + + β + + - + + + +
2 371 - + + +++ + + + β + + - + + + +
3 c10 - - + +++ + + + β + + - + + + +
4 1601(1) + - + +++ + + + β + + - + + + +
5 1453(1) - - - +++ + + + β + + - + + -
6 2469(1) - - - +++ + + + β - - + + - - -
7 5711(1) + - + +++ - + + β + + - + + + +
8 R2 - - - +++ - + + β + + - + + - +
9 c03 - - - +++ - + - β + + - + + - -
10 2576(1) - - - +++ - + - β + + - + + - +
11 DU - - - + + - - δ + + - + + + -
12 DR - - - - + - - δ - - - + + - +
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precipitate around culture due to esculetol released under
the action of beta-galactosidase was considered positive
reaction.
Evaluation of biofilm development on inert substrata
was assessed by the microtiter method. Overnight bacter-
ial cultures were grown in 96 multi-well plates containing
Tryptic Soy Broth (TSB) for 24 h at 37 °C, then the plate
was emptied and washed three times with phosphate buff-
ered saline (PBS). The adherent cells were then fixed with
cold methanol, stained with an alkaline 1 % violet crystal
solution for 15 min, washed with water and resuspended
in a 33 % acetic acid solution. The intensity of the suspen-
sion was spectrophotometrically assessed, the amount of
adhered biomass being proportional to the absorbance
value read at 492 nm.
Evaluation of the bacterial adherence to cellular substrata
(HeLa cells)
For the adherence assay, Cravioto’s adapted method was
used [11, 12]. Briefly, HeLa cell monolayers were washed
with PBS and 1 ml of fresh medium without antibiotics was
aseptically added to each well. The suspensions of P. aeru-
ginosa obtained from mid-logarithmic phase cultures
grown in nutrient broth were adjusted to 107 colony
forming units (CFU)/ml and 1 ml was used for the inocula-
tion of each well. After two hours of incubation at 37 °C
the monolayers were washed 3 times with PBS, fixed in
ethanol (3 min) and stained with 1:10 v/v Giemsa solution
for 20 min. The plates were washed, dried at room
temperature overnight, and examined by optic microscopy
using wet objective (×1000 magnification), in order to
evaluate the adherence indexes and patterns. The adher-
ence indexes were expressed as the ratio between the num-
ber of the eukaryotic cells with adhered bacteria and 100
eukaryotic cells counted on the microscopic field. The
adherence patterns were defined as: localized adherence
(LA) when tight clusters of microorganisms were noticed
on the HeLa cell surface, aggregative adherence (AA) when
a microbial stacked brick pattern characterized the attach-
ment, diffuse adherence (DA) when the bacteria adhered
diffusely, covering the whole surface of the cell [13].
Evaluation of the bacterial invasion capacity
To determine the invasion ability the antibiotic protec-
tion assay was used [14, 15]. Bacterial suspensions were
inoculated in duplicate on HeLa cells grown in 6-well
plates and incubated at 37 °C for two hours. The infec-
tion assay was performed in the same manner as the
adherence assay, but after the incubation period in one
of two wells inoculated with each strain 100 μg/ml gen-
tamicin was added in order to kill extracellular bacteria.
The plates were further incubated for another hour; after
incubation, plates were washed 3 times with PBS and the
HeLa cells were permeabilized with 0.1 % Triton X-100
for 10 min, at 37 °C. Serial dilutions of suspended cells
harvested were seeded on nutritive agar (three technical
replicates for each dilution) in order to establish the inva-
sion indexes, calculated as CFU/ml.
Evaluation of the antibiotic susceptibility
The antibiotic susceptibility testing was performed by
Kirby-Bauer standard disk diffusion method (panels of
antibiotic disks recommended by CLSI, 2013, 2014,
2015).
PCR assays for virulence genes detection
The genetic support of the virulence factors was investi-
gated by simplex and multiplex PCR, using a reaction mix
of 20 or 25 μl (PCR Master Mix 2x, Thermo Scientific)
containing 1 μl of bacterial DNA extracted using the
alkaline extraction method. In this purpose, 1–5 colonies
of bacterial cultures were suspended in 1.5 ml tubes
containing 20 μl solution of NaOH (sodium hydroxide)
and SDS (sodium dodecyl sulphate) and heated on a ther-
moblock at 95 °C for 15 min. for the permeabilization of
bacterial wall. The following step was the addition of
180 μl of TE buffer (TRIS + EDTA) 1X and centrifugation
at 13000 rpm for 3 min. All PCR reactions were
Fig. 1 Graphic representation of enzymatic virulence factors expression
Fig. 2 Graphic representation of adherence to inert substratum: all
strains exhibited adherence capacity, the highest level being observed
in the case of 1453(1), c03 and DR strains. The number of adherent
bacteria was determined by measuring the absorbance at 490 nm
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performed using the Thermal Cycler machine Corbet.
Genomic DNA was used as a template for the PCR
screening of 7 virulence genes encoding for protease IV,
three exoenzymes – exoS, exoT, exoU, two phospholipases
- plcH (haemolytic phospholipase C) and plcN (non-
haemolytic phospholipase C) and for alginate. The PCR
reactions were initiated with 1 cycle at 95 °C for 2 min,
followed by 30 cycles at 94 °C for 30 s, 58 °C for 30 s, 72 °
C for 1 min and a final elongation step at 72 °C for 7 min.
The amplification products were visualized by electro-
phoresis on a 1 % agarose gel, stained with the specific
weight marker (100pb, Ladder Bench Top, Promega,
USA).
Results and discussion
In the present study, from 130 bacterial strains isolated
from chronic leg ulcers of hospitalized patients, only 12
(9.23 %) were P. aeruginosa, accounting for a smaller
percentage comparing with the number of cases reported
in other studies. For example, in a study of Wolcott et al.
(2015) performed on 2,963 patients with chronic wounds,
P. aeruginosa represented 25 % from the total number of
the isolated strains [16].
The isolated strains expressed between one and six of
the seven investigated soluble virulence factors (Table 1).
The most frequently expressed soluble virulence factors
were caseinase (91.67 %) followed by beta haemolysins
and lipase (83.33 %) (Fig. 1). Production of proteases by
the majority of the tested strains indicates the ability of
these strains to induce tissue lesions and to delay the
wound healing. The pore forming enzymes, i.e. beta
haemolysins, lecithinase (66.67 %) and lipase play an im-
portant role in dissemination of infection and wound
extent. Although some studies [17] reported an increased
expression of DNase in the strains isolated from wound
secretions, in our study only 2 of the 12 strains of P. aeru-
ginosa produced DNase (16.67 %).
Regarding the cell-associated virulence factors, the
analyzed strains showed variable rates of adherence to
the inert substratum (Fig. 2). This adherence phenotype
is correlated with the high capacity of P. aeruginosa
strains to develop complex biofilm structures [18], as-
pect that can explain the persistence of this bacterium in
the organism, and also its high antibiotic resistance.
Fig. 3 Different adherence patterns of P. aeruginosa analyzed strains: a- control, b- localized pattern, c- aggregative pattern (1000X)
Fig. 4 Graphic representation of adherence and invasiveness rates
of P. aeruginosa –the number of colony forming units of adherent
and invasive bacteria (green) and invasive bacteria (treated with
gentamicin) (red) - all the strains adhered to the cellular substrate
and also succeeded to invade the cells, some of them showing a
high invasive capacity (strains no 1, 2, 4 and 5)
Fig. 5 Antibiotic resistance profiles (%) among isolated
Pseudomonas strains
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P. aeruginosa analyzed strains exhibited different in-
dexes of adherence to the cellular substratum represented
by HeLa cells, ranging from 12 to 100 %. All the adher-
ence patterns to HeLa were observed, but mostly the
localized pattern was revealed (Fig. 3).
The analyzed strains proved the ability to invade the
cellular substratum, which was somehow expected due
to the presence of pore forming enzymes that cause
pores in the cell membranes, and facilitate internaliza-
tion of the bacteria in the host cells (Fig. 4, Table 1).
The ability of P. aeruginosa to survive in host cells
may explain some aspects of host-pathogen relationship.
The ability of bacteria to invade eukaryotic cells could
protect them against host defense and antibiotic treatment
facilitating the recurrent chronic diseases and long-term
colonization process.
P. aeruginosa strains isolated from chronic leg wound
were resistant in high proportions to ticarcillin, to third
and fourth generation cephalosporins and to ciprofloxacin.
Only one strain demonstrated resistance to imipenem and
meropenem (Fig. 5). None of the isolated strains
demonstrated resistance to colistin. A recent study in
Romania [18] identified 4 strains of P. aeruginosa showing
comparable resistance rates to antibiotics.
On the other hand, international data demonstrate vari-
able resistance: one study revealed strains isolated from
chronic wounds resistant to piperacillin/tazobactam and
aztreonam [18], another study found P. aeruginosa strains
100 % susceptible only to imipenem and meropenem,
followed by ceftazidime (86 %) and amikacin, aztreonam,
cefepime, ciprofloxacin, and piperacillin tazobactam (57 %
each) [19]; opposite, another study found only 11.5 % re-
sistance to imipenem (out of a collection of 512 P. aerugi-
nosa strains), 66 % of the strains resistant to streptomycin,
and 25.2 % and 28.5 % respectively were resistant to
aminoglycoside antibiotics ciprofloxacin and gentamicin,
respectively, polymyxin B having the greatest antibacterial
activity (4.9 % resistant strains to this antibiotic) [20].
Fig. 6 Percentage distribution of virulence genes in analyzed strains
Fig. 7 Electrophoresis gel for PlcH (466pb) and PlcN (307pb) genes: all the
tested strains except no. 2469 and DR revealed the two phospholipases.
Lines: PCR Marker (Promega) - 100pb, 1 - 2469, 2- DU, 3- DR, 4- 571(1),
5- 1453, 6- C03, 7- 1333, 8- 2576, 9- 371, 10-C10, 11- 601, 12- R2
Fig. 8 Electrophoresis gel of AlgD gene. The figure shows that all the
analyzed strains except one (the strain DR) are positive for the respective
gene. Lines: PCR Marker (Promega) - 100pb, 1-R2, 2-1333(1); 3-5711,
4-1453, 5-2576, 6-C10, 7-2469, 8-DR, 9-1601, 10-371, 11-C03, 12-DU
Fig. 9 Electrophoresis gel of ExoU and ExoT genes: the figure shows
that all the isolates revealed the ExoT. 2469 expressed the ExoU
gene. Lines: PCR Marker (Promega) - 100pb, 1-2469, 2-DR, 3-5711,
4-1453, 5-C03, 6-1333(1), 7-2576, 8-371, 9-C10, 10-R2, 11-DU, 12-1601
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The molecular analysis through PCR arrays showed that
all the analyzed strains revealed the ExoT gene, 92.3 % of
the isolates expressed AlgD gene, 84.6 % of the strains
revealed plcH and plcH genes, 61.5 % of P. aeruginosa
expressed the gene codifying for protease IV (TCF/TCR)
and only 1 strain expressed the ExoU gene (Fig. 6).
Multiple bacterial virulence factors impact the patho-
genesis of P. aeruginosa infections. The combination of
virulence factors expressed by each P. aeruginosa strain
tends to determine the outcome of an infectious process.
In the hospitals units, it is often difficult to distinguish
between colonization and infection, and no diagnostic
tool is available to assess the virulence potential of a
given isolate [21, 22]. Among P. aeruginosa isolates three
soluble proteins are responsible for invasion: a rhamnoli-
pid and two phospholipases C (haemolytic phospholip-
ase C (plcH), and non-haemolytic phospholipase C
(plcN)) [23]. These two phospholipases could work
synergistically, plcH would promote degradation of the
erythrocyte membrane (phospholipids components of
the outer leaflet: phosphatidylcholine and sphingomye-
lin), exposing the inner leaflet. Plc-N could then
hydrolyze phosphatidylserine present in the inner leaflet.
Our results of genotyping analysis showed that 84.6 % of
the P. aeruginosa isolates possess phospholipases genes
(Figs. 6 and 7) compared with other studies from our
country in which only the plcH gene was revealed in the
strains isolated from blood cultures and wound secretions
[17]. The phospholipase gene expression is sustained at
phenotypic level, the same strains being positive for lipase
production.
Our PCR results concerning the presence of algD gene
showed that 92.3 % of the isolates express this gene (Fig. 8).
The algD gene encodes GDP-mannose dehydrogenase,
which acts as a rate-limiting enzyme in mucoid strains by
catalyzing the conversion of GDP-mannose to GDP-
mannuronic acid, thereby promoting the cell to alginate
production [24], which demonstrates the involvement of
these strains in infections with biofilm formation [23].
And indeed, the high level of AlgD gene expression corre-
lates with phenotypic results, adherence to inert substra-
tum being also observed among tested strains (Table 1).
It is known that the exotoxins ExoS, ExoY, and ExoT in-
hibit invasion, while ExoU confers cytotoxicity [25–27].
ExoT and ExoS act on a number of host small G proteins,
thus altering the cytoskeleton and signaling pathways [28].
The results of Shaver and Hauser indicate that ExoU has
the greatest effect on virulence of the type III secreted
proteins [29]. The concomitant presence of ExoU and
ExoS was also revealed by one isolate of P. aeruginosa
(Figs. 9 and 10).
The isolated strains of P. aeruginosa exhibited a high
frequency of protease IV (TCF/TCR), which plays a role
in tissue injuries (Fig. 11). Holban A.M. et al. [17] re-
ported the highest frequency of plcH and protease IV
genes in P. aeruginosa strains analyzed in their study.
Conclusions
Our phenotypic and molecular results demonstrate that
the analyzed P. aeruginosa strains express virulence fea-
tures which explain the survival and implication of these
strains in the poor prognosis of chronic leg wounds. The
phenotypic virulence markers were correlated with some
specific virulence genes profiles, revealing that the isolates
could adapt easily to the microenvironment encountered
within the host by modulating the expression of these
genes. Furthermore, the diversity of virulence factors ex-
pression explains the large panel of clinical manifestations
in Pseudomonas aeruginosa infections. All the data result-
ing from this study, the first of its kind in our country,
could help clinicians to achieve correlations between clin-
ical manifestations and the virulence of the involved strain
and to adjust the therapeutic approach, consequently.
Fig. 10 Electrophoresis gel of ExoS gene: the positive strains are 1333,
5711, 1601, 371, c10, DU. PCR Marker (Promega) - 100pb, 1-R2, 2-1333(1);
3-5711, 4-1453, 5-2576, 6-C10, 7-2469, 8-DR, 9-1601, 10-371,
11-C03, 12-DU
Fig. 11 Electrophoresis gel of protease IV (TCF/TCR) the positive
strains are no. 1333, 371, C10, 2576, 5711, R2, 1601, DR. Lines: PCR
Marker (Promega) - 100pb, 1-1453, 2-DU, 3-2576, 4-5711, 5-R2,
6-1601, 7-2469, 8-DR, 9-1333(1), 10-371, 11-C03, 12-C10
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